Merck | MRK - Operating Expenses



Merck reported EUR4.22B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Adidas EUR 5.4B 138M Jun/2025
Adyen EUR 682.55M 413.38M Dec/2024
Akzo Nobel EUR 2.32B 98M Jun/2025
Alcon AG USD 2.35B 344M Jun/2025
Amadeus IT EUR 1.13B 36.8M Jun/2025
Amarin USD 58.77M 56.06M Mar/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
BASF EUR 14.94B 1.26B Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Beiersdorf EUR 4.37B 143M Jun/2025
Covestro EUR 3.33B 244M Jun/2025
Danone EUR 11.92B 131M Jun/2025
Fresenius EUR 5.02B 57M Jun/2025
Fresenius Medical Care EUR 4.36B 189M Jun/2025
Galapagos EUR 122.32M 111.37M Jun/2025
Genmab DKK 565M 38M Jun/2025
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 5.96B 663M Jun/2025
GRIFOLS EUR 1.54B 24.64M Jun/2025
Henkel EUR 8.79B 620M Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Infineon EUR 3.17B 98M Jun/2025
Linde USD 6.16B 144M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.22B 49M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Philips EUR 3.85B 93M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Sanofi EUR 9.02B 702M Jun/2025
UCB EUR 2.36B 108M Dec/2024